High Incidence of MGMT and RARβ Promoter Methylation in Primary Glioblastomas: Association with Histopathological Characteristics, Inflammatory Mediators and Clinical Outcome-Reference-Cited by-同舟云学术

High Incidence of MGMT and RARβ Promoter Methylation in Primary Glioblastomas: Association with Histopathological Characteristics, Inflammatory Mediators and Clinical Outcome

Published:2009-10-12 Issue:1-2 Volume:16 Page:1-9
ISSN:1076-1551
Container-title:Molecular Medicine
language:en
Short-container-title:Mol Med

Author:

Piperi Christina,Themistocleous Marios S.,Papavassiliou George A.,Farmaki Elena,Levidou Georgia,Korkolopoulou Penelope,Adamopoulos Christos,Papavassiliou Athanasios G.

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.2119/molmed.2009.00140.pdf

Reference46 articles.

1. Hsieh JC, Lesniak MS. (2005) Surgical management of high-grade gliomas. Expert Rev. Neurother. 5:33–9.

2. Maher EA, et al. (2001) Malignant glioma: genetics and biology of a grave matter. Genes. Dev. 15:1311–33.

3. Cavenee WK, et al. (2000) Diffusely infiltrating astrocytomas. In: Pathology and Genetics of Tumours of the Nervous System. 2nd ed. Kleihues P, Cavenee WK (eds.) IARC Press, Lyon. pp. 10–21.

4. Burger PC, Green SB. (1987) Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 59:1617–25.

5. Esteller M. (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 21:5427–40.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RAR-Dependent and RAR-Independent RXR Signaling in Stem-like Glioma Cells;International Journal of Molecular Sciences;2023-11-17

2. Methylation of RARß is a New Clinical Biomarker for Treatment in Higher-grade Gliomas;Neurological Sciences and Neurophysiology;2023

3. Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma;Cells;2022-08-15

4. Epigenetic Underpinnings of Inflammation: A Key to Unlock the Tumor Microenvironment in Glioblastoma;Frontiers in Immunology;2022-04-29

5. Targeting post-translational histone modifying enzymes in glioblastoma;Pharmacology & Therapeutics;2021-04